News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Election 2014, Local

Inversion Discussion

Fresh
oberweiss

Durbin's Walgreen-inspired idea "stupid," says Oberweis

in Local

Quinn Touts Workers’ Comp Drop

Fresh
pat-quinn

IMA's Baise: It's a good start

in Local

Madigan Lauds New Epi-pen Law

Fresh
lisa madigan

Schools not yet required to stock epi-pens

in Local

Motorcycle Accident Kills Man Wednesday on North Side

cycle fatal

Intersection near Lanphier closed for several hours

in Local

Human Remains in Rochester Identified

rochester police

The Sangamon County Coroner's Office has identified the female remains found in Rochester on July 19th.